61703-350-10 · Methotrexate Sodium Injection · Hospira, Inc., a Pfizer Company
What is the status for 61703-350-10 · Methotrexate Sodium Injection · Hospira, Inc., a Pfizer Company?
For 61703-350-10, generic name is Methotrexate Sodium Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available; initial posting date is 03/13/2023, recorded from its source on 2026-11-04.
"initial_posting_date": "03/13/2023", "package_ndc": "61703-350-10", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 61703-350-10 verified
- Generic name
- Methotrexate Sodium Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Available verified
- Initial posting date
- 03/13/2023 verified
- Last update date
- 10/29/2026 verified
- Days in shortage
- 1332 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Rheumatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-350-10", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "status": "Current", "dosage_form": "Injection"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000